Results

Total Results: 376 records

Showing results for "renal".

181. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - Reticulocyte indices in patients with end stage renal disease on hemodialysis. … Contribution of iron deficiency to anemia in chronic renal failure. … to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal … Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. … With Chronic Kidney Disease Not yet recruiting Drug: Cholecalciferol 28 NCT01138241 Tenofovir Renal

182. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
     May 14, 2010 - in December 2008 regarding the possible association of the use of pamidronate with deterioration of renal … Drug Labeling Change to Pamidronate (Aredia) Regarding Link to Renal Failure.

183. Cad-Women-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
     August 01, 2012 - treatment strategy (i.e., adverse drug reactions, radiation exposure, access site complications, renal … treatment strategy (i.e., adverse drug reactions, radiation exposure, access site complications, renal … treatment strategy (i.e., adverse drug reactions, radiation exposure, access site complications, renal … effects of interventions: adverse drug reactions, radiation exposure, access site complications, renal … CABG can result in wound infections, renal dysfunction, and bleeding.

184. Diagnosis and Management of Gout: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
     January 01, 2017 - be considered (e.g., possible contraindications of NSAIDs in patients with cardiovascular disease, renal

185. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … unknown, but the disorder also occurs secondary to other conditions such as iron deficiency, end-stage renal … No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically excluded … Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With RLS and End- Stage Renal … GEn 1200/6000mg; Placebo; Moxifloxacin NCT00422994 A Study To Investigate The Effects Of End Stage Renal

186. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
     November 19, 2009 - For example, intact parathyroid hormone (PTH) measurements are used to manage patients with renal osteodystrophy … of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal

187. Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research

188. Disposition of Comments for Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
     November 24, 2014 - More information regarding patients’ baseline characteristics, particularly renal clearance, APACHE … results section, we have added more details when available on baseline characteristics, particularly renal … In the Results section we added data on baseline characteristics, particularly renal clearance, APACHE … , or antibiotic-related adverse events differ for subgroups defined by age, sex, race, ethnicity, renal

189. Disposition of Comments_Systematic Review_The Effect of Protein Intake on Health: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-disposition-comments.pdf
     November 22, 2024 - A Systematic Review of Renal Health in Healthy Individuals Associated with Protein Intake above the

190. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
     December 29, 2020 - Renal harms were not reported in the trial, likely in part because of the short duration of symptoms … NSAIDs We advocate ensuring that acute kidney injury and other renal issues are included in the adverse … Findings regarding acetaminophen versus opioids for renal colic are based on a large, good-quality … Renal colic. … standard for severe acute pain for centuries, are probably less effective than acetaminophen for renal

191. Autism-Update Espanol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_espanol.pdf
     November 01, 2014 - vigilancia médica, estos productos pueden causar daños graves, entre ellos deshidratación, insuficiencia renal

192. Mixed MethodsReview -Integrating Palliative Care with Chronic Disease Management in Ambulatory Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
     November 21, 2019 - disease (Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria III or IV), end- stage renal … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage renal … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage renal

193. Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
     November 01, 2023 - Acamprosate is contraindicated in patients with severe renal impairment.

194. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
     September 13, 2012 - Major—renal toxicity, hepatic toxicity, gastrointestinal upset c. … multiple daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Abbreviations: C. diff

195. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
     January 30, 2020 - transplantation : official publication of the European Dialysis and Transplant Association - European Renal … of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal … Renal failure. 2015;37(7):1080-8. 105. Zafack JG, De Serres G, Kiely M, et al. … Nervous system disorders • Pregnancy, puerperium and perinatal conditions • Psychiatric disorders • Renal

196. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - 2) Page ES-15 bullet 11 describes information concerning the effects of some drugs by baseline renal … function subgroup, and there was no evidence that these increases were altered by renal insufficiency … reductions were similar and did not differ significantly between patients with normal or impaired renal … No particular safety issues were identified in subgroups defined by renal function. … Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

197. Calcineurin Inhibitors for Kidney Transplant | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/calcineurin-inhibitor/research

198. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
     March 01, 2010 - Clinically significant comorbidities were more frequent in the group receiving H-ISDN; for example, renal … 39.7% 54 <.0001 Diabetes (complicated) 15.3% 27 <.0001 Hypothyroidism 5.1% 4.2 0.01 Renal

199. Diabetes-Behavior-Programs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
     June 05, 2014 - glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal

200. Recurrent Nephrolithiasis in Adults: A Comparative Effectiveness Review of Preventive Medical Strategies | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/kidney-stone-prevention/research-protocol